Arginine Human Insulin generally refers to Arginine Human Insulin Mix Injection and is not a long-acting insulin. The components of this product contain short-acting insulin and intermediate-acting insulin. Arginine Human Insulin Mix Injection can promote the uptake and utilization of glucose by bones, liver and adipose tissue, promote the conversion of glucose into glycogen for storage in the liver and muscle, inhibit gluconeogenesis, and then lower blood glucose, and can be used for the treatment of diabetes mellitus. Patients who are allergic to this drug, hypoglycemic episodes, etc. should not be treated with this drug. Adverse reactions such as hypoglycemia and allergic reactions may occur after the use of the drug. Patients who need to use Arginine Human Insulin Mix Injection should use the drug under the guidance of a doctor.